scholarly journals Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)

2010 ◽  
Vol 25 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Andres Forero-Torres ◽  
Jatin Shah ◽  
Tina Wood ◽  
James Posey ◽  
Ronda Carlisle ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Trial ◽  
Death Receptor ◽  
Death Receptor 5 ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

scholarly journals A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors

2019 ◽  
Vol 37 (5) ◽  
pp. 1061-1074 ◽  
Author(s):  
Toshihiko Doi ◽  
Takeshi Aramaki ◽  
Hirofumi Yasui ◽  
Kei Muro ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

240 Molecular imaging of Death Receptor 5 (DR5) occupancy in-vivo by humanized monoclonal antibody CS-1008

2010 ◽  
Vol 8 (7) ◽  
pp. 78
Author(s):  
A.M. Scott ◽  
F.T. Lee ◽  
G.C. Cartwright ◽  
G.J. O'Keefe ◽  
R.A. Beckman ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Molecular Imaging ◽  
Death Receptor ◽  
Death Receptor 5 ◽  
Humanized Monoclonal Antibody

scholarly journals Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors

2017 ◽  
Vol 17 (1) ◽  
pp. 215-221 ◽  
Author(s):  
Elaine T. Lam ◽  
S. Gail Eckhardt ◽  
Wells Messersmith ◽  
Antonio Jimeno ◽  
Cindy L. O'Bryant ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3

2015 ◽  
Vol 75 (5) ◽  
pp. 1065-1073 ◽  
Author(s):  
Morten Mau-Sørensen ◽  
Christian Dittrich ◽  
Rodrigo Dienstmann ◽  
Ulrik Lassen ◽  
Wilfried Büchler ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
T Cell ◽  
Phase I ◽  
Phase I Trial ◽  
Bispecific Monoclonal Antibody ◽  
Antibody Targeting
Sign in / Sign up

Export Citation Format

Share Document